Biotek-snakken — Juni 2020
-
Vi forventer jo at det er positive data, som har medført at de nu rekruttere i stage II i cohort B . Succeskriteriet var dog kun 1 PR i stage I for at gå i stage II. De har dog ændret i pat. rekrutteringen så det kun er 2L pat. der kan komme med. Hvilket jeg tolker som at de har haft succes med 2 L pat. (kun) i stage I. Så tallene kan være meget små men gode nok til at gå i stage II. Just my 5 cents
-
Så er det i dag der kommer CHMP opinion for Hansa Biopharma. Det bliver godt nok spændende....
-
Om Scandion Oncology fra 17 min. inde i udsendelsen: https://www.youtube.com/watch?v=6A4kXoW77us
-
Og Hansa fik positiv CHMP https://www.di.se/bors/telegram/6679d96e-0477-4a85-9b72-3c6717bfa6c5
-
Fedt med Hansa.
-
Er du med Helge?
-
BergenBio - Positive data - ser lovende ud -"6 of 7 checkpoint inhibitor refractory cAXL-positive patients report clinical benefit". https://finance.yahoo.com/news/bergenbio-announces-positive-interim-clinical-173000357.html
-
BergenBio - aftenens præsentation på Next Gen Immuno-Oncology Congress 25 June 2020 - https://www.bergenbio.com/wp-content/uploads/2020/06/Next-Gen-IO-Presentation-25-June-2020.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind